New GlaxoSmithKline CEO Pulling Back On Predecessor’s Expansion Plans For Africa
Reuters: Drugmaker GSK cuts back in Africa to hone emerging markets model
“GlaxoSmithKline is cutting back operations in Africa as its new Chief Executive Emma Walmsley seeks to make the British drugmaker more competitive in emerging markets by ditching her predecessor’s expansion plans for the continent…” (Hirschler, 1/17).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.